Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by toinv261on Jun 11, 2014 3:28pm
150 Views
Post# 22650616

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:DIRECTORS AND OFFICERS OF RVX PARTICIPATE IN PRIVATE PLACEME

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:DIRECTORS AND OFFICERS OF RVX PARTICIPATE IN PRIVATE PLACEMEHi GV.

Perhaps I missed the point on this announcement. 

I had assumed that the insiders bought (paid for) 1,080,522 shares at a cost of $702,339.30. That is, they took their own money and paid this amount into RVX in oerder to keep things rolling.

Then NGN added more as well.

This suggested to me that there is a clear vote of confidence in the future of the company. For example, let's say that Don took $100,000 of his $500,000 salary and invested in these $.65 shares it is a clear signal to me that he must have a very serious level of confidence in the future of this company. He could have easily taken the same $100,000 and invested in a secure dividend paying blue chip stock at 4% to 5% interest almost guaranteed.

I don't really know. I'm in the communications vacuum like all of us but I believe this announcement is huge IMO.

The fact that these guys could get the stock at $.65 is irritating.

Please let me know if I am wrong in my assumptions.
Cheers
Toinv


Bullboard Posts